First FDA-approved CAR T Cell Therapy for Lymphoma to Be Available at City of Hope

October 18, 2017 | City of Hope

City of Hope will be the one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. FDA announced today is the first approved CAR T therapy for adult patients for some types of non-Hodgkin lymphoma

Continue Reading

Research Grant Roundup

October 31, 2017 | City of Hope

Review the latest City of Hope grant awardees.

Prehistoric Virus May Hold Secret to Fighting Certain Types of Cancer

October 25, 2017 | Katie Neith

City of Hope researchers have found a link between a type of ancient RNA and a tumor suppressing gene.

History of Hope: Susumu Ohno

October 23, 2017 | Katie Neith

In 1952, a young researcher named Susumu Ohno came to City of Hope. Though he was only a research associate at the time, his research would soon make waves in the scientific community.

Oncologist George Somlo Named Director of Pharmaceutical Initiatives

October 16, 2017 | City of Hope

George Somlo, M.D., an internationally known breast cancer and hematology researcher at City of Hope, has been named director of pharmaceutical initiatives at City of Hope.

New Hire: Andrea Bild, Ph.D.

October 11, 2017 | City of Hope

Andrea Bild, Ph.D., serves as professor in the Division of Molecular Pharmacology within the Department of Medical Oncology & Therapeutics Research.

New Hire: Jianjun Chen, Ph.D.

October 11, 2017 | City of Hope

Jianjun Chen, Ph.D., joined Beckman Research Institute of City of Hope as a full professor and associate chair of the Department of Systems Biology in October 2017.

New Hire: Michael Kahn, Ph.D.

October 11, 2017 | City of Hope

Michael Kahn, Ph.D., has joined City of Hope as professor and associate chair in the Department of Molecular Medicine. 

New Hire: Nora Heisterkamp, Ph.D.

October 11, 2017 | City of Hope

Nora Heisterkamp, Ph.D., has joined City of Hope as a full professor in the Department of Systems Biology. 

Load More